PBS adds Spravato for treatment-resistant depression
Starting May 1, 2025, Australians suffering from treatment-resistant depression will gain access to Spravato (esketamine), a new nasal spray treatment…
Starting May 1, 2025, Australians suffering from treatment-resistant depression will gain access to Spravato (esketamine), a new nasal spray treatment…
Beginning May 1, 2025, Australians suffering from treatment-resistant depression will have access to a new medication, esketamine, under the Pharmaceutical…
A new nasal spray using a form of ketamine will soon be available to treat severe depression in Australia, as…
A new ketamine nasal spray, known as Spravato (esketamine hydrochloride), will be subsidized under Australia’s Pharmaceutical Benefits Scheme (PBS) starting…